Sensus Healthcare, Inc.
SRTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $41,807 | $24,405 | $44,532 | $27,042 |
| % Growth | 71.3% | -45.2% | 64.7% | – |
| Cost of Goods Sold | $17,376 | $10,345 | $14,904 | $10,054 |
| Gross Profit | $24,431 | $14,060 | $29,628 | $16,988 |
| % Margin | 58.4% | 57.6% | 66.5% | 62.8% |
| R&D Expenses | $4,216 | $3,678 | $3,460 | $3,436 |
| G&A Expenses | $7,147 | $5,156 | $5,008 | $4,594 |
| SG&A Expenses | $12,125 | $10,764 | $11,337 | $9,432 |
| Sales & Mktg Exp. | $4,978 | $5,608 | $6,329 | $4,838 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $16,341 | $14,442 | $14,797 | $12,868 |
| Operating Income | $8,090 | -$382 | $14,831 | $4,120 |
| % Margin | 19.4% | -1.6% | 33.3% | 15.2% |
| Other Income/Exp. Net | $932 | $1,034 | $13,159 | -$1 |
| Pre-Tax Income | $9,022 | $652 | $27,990 | $4,119 |
| Tax Expense | $2,375 | $167 | $3,746 | $0 |
| Net Income | $6,647 | $485 | $24,244 | $4,119 |
| % Margin | 15.9% | 2% | 54.4% | 15.2% |
| EPS | 0.41 | 0.03 | 1.47 | 0.25 |
| % Growth | 1,275.8% | -98% | 488% | – |
| EPS Diluted | 0.41 | 0.03 | 1.46 | 0.25 |
| Weighted Avg Shares Out | 16,312 | 16,259 | 16,481 | 16,476 |
| Weighted Avg Shares Out Dil | 16,360 | 16,266 | 16,618 | 16,503 |
| Supplemental Information | – | – | – | – |
| Interest Income | $932 | $992 | $382 | $2 |
| Interest Expense | $0 | $0 | $2 | $1 |
| Depreciation & Amortization | $432 | $461 | $509 | $613 |
| EBITDA | $8,522 | $79 | $15,340 | $4,734 |
| % Margin | 20.4% | 0.3% | 34.4% | 17.5% |